Pediatric palliative care is specialized medical care for children living with a serious illness. Palliative care focuses on providing relief from the symptoms and stress of the illness. The goal is to improve quality of life for both the child and the family. Pediatric palliative care is appropriate at any age and any stage of illness. It is appropriate for neonates, perinates, infants, children, adolescents, and young adults, and it can be provided along with treatment. Pediatric palliative care addresses serious medical conditions including genetic disorders, cancer, prematurity, neurologic disorders, heart and lung conditions, and others. It relieves the symptoms of these diseases such as pain, shortness of breath, fatigue, constipation, nausea, loss of appetite and difficulty sleeping, anxiety and depression. In short, it helps the child and the family improve their quality of life. Pediatric palliative care is an interdisciplinary collaboration that seeks to improve the quality of life for children with life-threatening conditions, as well as their families. The World Health Organization (WHO) defines pediatric palliative care as the active total care of the child's body, mind and spirit, which also involves giving support to the family. Different drugs most commonly used in palliative care are paracetamol, ibuprofen, morphine, bisacodyl, metronidazole, domperidone, dexamethasone, and diazepam. It is also used to treat serious disorders like chronic diseases such as kidney failure, Amyotrophic Lateral Sclerosis (ALS), cancer, Parkinson’s disease, Chronic Obstructive Pulmonary Disease (COPD), and Congestive Heart Failure (CHF).

Market Dynamics

Increasing new product launches, and mergers and acquisitions by key market players are expected to drive the global pediatric palliative care drugs market growth. For instance, on April 1, 2022, Eisai Co., Ltd., a Japan-based pharmaceutical company announced the acquisition of Arteryex Inc., a Japan-based healthcare blockchain startup, to strengthen and rapidly expand the foundation of its digital solution business. The two companies will work together to develop and provide Personal Health Record (PHR)-related services for patients, healthcare professionals, and society at large.

Key features of the study:

• This report provides an in-depth analysis of the global pediatric palliative care drugs market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pediatric palliative care drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pediatric palliative care drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric palliative care drugs market

Detailed Segmentation:

• Global Pediatric Palliative Care Drugs Market, By Drug Class:
  • Analgesics
  • Anti‐emetics
  • Laxatives
  • Adjuvant Medications
  • Steroids
  • Sedatives
  • Neuroleptic Medications
  • Others
• Global Pediatric Palliative Care Drugs Market, By Route of Administration:
  • Oral
  • Topical
  • Parenteral
• Global Pediatric Palliative Care Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Pediatric Palliative Care Drugs Market, By Region:
  • North America 
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Novartis International AG
  • Mylan NV
  • Teva Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • Anqiu Lu'an Pharmaceutical Co., Ltd.
  • Granules India Limited
  • Zhejiang Kangle Pharmaceutical Co., Ltd.
  • Farmson Pharmaceutical Gujarat Pvt. Ltd.
  • Atabay Pharmaceutical Factory
  • Anhui Fubore Pharmaceutical & Chemical Co., Ltd
  • Huzhou Konch Pharmaceutical Co., Ltd.
  • Alnylam Pharmaceuticals Inc.
  • Eton Pharmaceuticals, Inc
  • Eisai Inc.